Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma

被引：0
|
作者：
Chang, A. S. [1 ]
Mohan, S. [3 ]
Chang, J. [1 ]
Wood, D. [2 ]
Henry, S. [2 ]
Li, S. [1 ]
机构：
[1] Stanford Univ, Dermatol, Redwood City, CA USA
[2] Stanford, Canc Res Database, Stanford, CA USA
[3] Genentech Roche, San Francisco, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2016年 / 136卷 / 05期
关键词：
D O I：
10.1016/j.jid.2016.02.183
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
156
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [1] Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma
    Mohan, Shalini V.
    Chang, Julia
    Li, Shufeng
    Henry, A. Solomon
    Wood, Douglas J.
    Chang, Anne Lynn S.
    [J]. JAMA DERMATOLOGY, 2016, 152 (05) : 527 - 532
  • [2] Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib
    Bhutani, Tina
    Abrouk, Michael
    Sima, Camelia S.
    Sadetsky, Natalia
    Hou, Jeannie
    Caro, Ivor
    Chren, Mary-Margaret
    Arron, Sarah T.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : 713 - 718
  • [3] Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study
    Gjersvik, Petter
    [J]. JAMA DERMATOLOGY, 2016, 152 (10) : 1172 - 1172
  • [4] Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study Reply
    Li, Shufeng
    Chang, Anne Lynn S.
    [J]. JAMA DERMATOLOGY, 2016, 152 (10) : 1173 - 1173
  • [5] Transformation of facial basal cell carcinoma to squamous cell carcinoma following vismodegib
    Silverman, Dustin A.
    Li, Michael M.
    Olencki, Thomas E.
    Seim, Nolan B.
    Teknos, Theodoros N.
    Kang, Stephen Y.
    [J]. OTOLARYNGOLOGY CASE REPORTS, 2021, 20
  • [6] Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib
    Saintes, C.
    Saint-Jean, M.
    Brocard, A.
    Peuvrel, L.
    Renaut, J. J.
    Khammari, A.
    Quereux, G.
    Dreno, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (05) : 1006 - 1009
  • [7] Vismodegib Therapy for Periocular Basal Cell Carcinoma
    Keser, M.
    Green, S.
    Dulz, S.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2017, 234 (01) : 64 - 69
  • [8] VISMODEGIB IN BASAL CELL CARCINOMA
    Amaria, R. N.
    Bowles, D. W.
    Lewis, K. D.
    Jimeno, A.
    [J]. DRUGS OF TODAY, 2012, 48 (07) : 459 - 467
  • [9] Regression of a basal cell carcinoma infiltrating the brain after vismodegib therapy
    Kaehler, Katharina C.
    Gutzmer, Ralf
    Egberts, Friederike
    Hauschild, Axel
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (10): : 906 - 907
  • [10] Shingles and pneumonia and risk of cutaneous basal and squamous cell carcinoma
    Drucker, Aaron M.
    Li, Wen-Qing
    Cho, Eunyoung
    Li, Tricia
    Besdine, Richard
    Qureshi, Abrar A.
    Linos, Eleni
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (02) : 492 - 495
12345